The Israeli Phage Therapy Center (IPTC), led by two Hebrew University of Jerusalem professors, has used a bacteriophage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections in 16 patients. It has shown promising results with an 86.6% success rate.
Phage therapy combats antibiotic resistance
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.